N. Al-Shar’i

发表

Molecular Dynamics Simulations of Adenosine Receptors: Advances, Applications and Trends.

N. Al-Shar’i, Qosay A. E. Al-Balas, 2019, Current pharmaceutical design.

Explaining the autoinhibition of the SMYD enzyme family: A theoretical study.

N. Al-Shar’i, Soraya Alnabulsi, 2016, Journal of molecular graphics & modelling.

Amino-carboxamide benzothiazoles as potential LSD1 hit inhibitors. Part I: Computational fragment-based drug design.

N. Al-Shar’i, Soraya Alnabulsi, T. El-Elimat, 2019, Journal of molecular graphics & modelling.

The Design and Functional Characterization of the Antimicrobial and Antibiofilm Activities of BMAP27-Melittin, a Rationally Designed Hybrid Peptide

N. Al-Shar’i, Qosay A. E. Al-Balas, A. Almaaytah, 2014, International Journal of Peptide Research and Therapeutics.

Evaluation and Characterization of Curcumin-β-Cyclodextrin and Cyclodextrin-Based Nanosponge Inclusion Complexation

N. Al-Shar’i, R. Obaidat, Hadeia Mashaqbeh, 2021, Polymers.

Dendrimers: Properties and Applications in Biomedical Field

K. N. Venugopala, N. Al-Shar’i, R. Tekade, 2021, Nanoengineering of Biomaterials.

1,2,3-Triazolyl-tetrahydropyrimidine Conjugates as Potential Sterol Carrier Protein-2 Inhibitors: Larvicidal Activity against the Malaria Vector Anopheles arabiensis and In Silico Molecular Docking Study

K. N. Venugopala, N. Al-Shar’i, R. M. Gleiser, 2022, Molecules.

Evaluation of EDTA Dianhydride Versus Diphenyl Carbonate Nanosponges for Curcumin

N. Al-Shar’i, R. Obaidat, Hadeia Mashaqbeh, 2022, AAPS PharmSciTech.

The impact of cycleanine in cancer research: a computational study

Mohammad K. Islam, N. Al-Shar’i, J. Stanslas, 2022, Journal of Molecular Modeling.

Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold

Mohammad A. Hassan, N. Al-Shar’i, Qosay A. E. Al-Balas, 2020, Acta pharmaceutica.

The impact of cycleanine in cancer research: a computational study

Mohammad K. Islam, N. Al-Shar’i, J. Stanslas, 2022, Journal of Molecular Modeling.

Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives

N. Al-Shar’i, M. Attimarad, Y. Bustanji, 2022, Antibiotics.

Weak complexation of 5-fluorouracil with β-cyclodextrin, carbonate, and dianhydride crosslinked β-cyclodextrin: in vitro and in silico studies

N. Al-Shar’i, T. El-Elimat, R. Obaidat, 2022, Research in pharmaceutical sciences.

Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking

N. Al-Shar’i, Qosay A. E. Al-Balas, B. Al-Oudat, 2020, Molecules.

Co-crystallization of Amoxicillin Trihydrate and Potassium Clavulanate Provides a Promising Approach for Preparation of Sustained-Release Microspheres

N. Al-Shar’i, R. Obaidat, B. Al-Taani, 2022, AAPS PharmSciTech.

Enhancement of levodopa stability when complexed with β-cyclodextrin in transdermal patches

N. Al-Shar’i, Tamara Athamneh, R. Obaidat, 2018, Pharmaceutical development and technology.

Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents

Mohammad A. Hassan, Nizar M. Mhaidat, N. Al-Shar’i, 2016, Drug design, development and therapy.

Synthesis and Anticandidal Activity of Azole‐Containing Sulfonamides

Mohammad A. Hassan, N. Al-Shar’i, A. Qandil, 2008, Archiv der Pharmazie.

Design, Synthesis and Biological Evaluation of Potential Novel Zinc Binders Targeting Human Glyoxalase-I; A Validated Target for Cancer Treatment

Mohammad A. Hassan, Ghazi A. Al Jabal, N. Al-Shar’i, 2018 .

Design, synthesis and biological evaluation of novel glyoxalase I inhibitors possessing diazenylbenzenesulfonamide moiety as potential anticancer agents.

N. Al-Shar’i, Qosay A. E. Al-Balas, B. Al-Oudat, 2020, Bioorganic & medicinal chemistry.

In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis

N. Al-Shar’i, P. Deb, M. Pillay, 2021, Journal of enzyme inhibition and medicinal chemistry.

Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted

N. Al-Shar’i, M. Goyal, Monika Bansal, 2021, Frontiers in Molecular Biosciences.

The Design and Functional Characterization of the Antimicrobial and Antibiofilm Activities of BMAP27-Melittin, a Rationally Designed Hybrid Peptide

N. Al-Shar’i, Qosay A. E. Al-Balas, A. Almaaytah, 2015, International Journal of Peptide Research and Therapeutics.

CHK1 kinase inhibition: identification of allosteric hits using MD simulations, pharmacophore modeling, docking and MM-PBSA calculations

N. Al-Shar’i, Sondos S Musleh, 2021, Molecular Diversity.

Hit identification of SMYD3 enzyme inhibitors using structure-based pharmacophore modeling.

N. Al-Shar’i, Soraya Alnabulsi, 2019, Future medicinal chemistry.

Perspectives on RNA Vaccine Candidates for COVID-19

N. Al-Shar’i, Lina A. Dahabiyeh, D. Jaradat, 2021, Frontiers in Molecular Biosciences.

The design of TOPK inhibitors using structure-based pharmacophore modeling and molecular docking based on an MD-refined homology model

N. Al-Shar’i, Lara I. Fakhouri, 2022, Molecular Diversity.

Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19

N. Al-Shar’i, Munir A. Al-Zeer, Rajashri Bezbaruah, 2021, Frontiers in Molecular Biosciences.

Current strategies in targeted anticancer drug delivery systems to brain

N. Al-Shar’i, R. Tekade, M. Goyal, 2021, Advanced Drug Delivery Systems in the Management of Cancer.

Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host-Di-rected Therapies.

V. Tiwari, N. Al-Shar’i, Vinayak Singh, 2020, Current topics in medicinal chemistry.

Discovery of a nanomolar glyoxalase-I inhibitor using integrated ligand-based pharmacophore modeling and molecular docking

Mohammad A. Hassan, N. Al-Shar’i, Qosay A. E. Al-Balas, 2019, Medicinal Chemistry Research.

Lead optimization and biological evaluation of diazenylbenzenesulfonamides inhibitors against glyoxalase-I enzyme as potential anticancer agents.

N. Al-Shar’i, Qosay A. E. Al-Balas, B. Al-Oudat, 2022, Bioorganic chemistry.

Tackling COVID-19: identification of potential main protease inhibitors via structural analysis, virtual screening, molecular docking and MM-PBSA calculations

N. Al-Shar’i, 2020, Journal of biomolecular structure & dynamics.

Discovery of a nanomolar inhibitor of the human glyoxalase-I enzyme using structure-based poly-pharmacophore modelling and molecular docking

Nizar A. Al-Shar’i, Qosay A. Al-Balas, Rand A. Al-Waqfi, 2019, Journal of Computer-Aided Molecular Design.

Computational and experimental exploration of the structure–activity relationships of flavonoids as potent glyoxalase‐I inhibitors

Mohammad A. Hassan, N. Al-Shar’i, Qosay A. E. Al-Balas, 2018, Drug development research.

Identification of CHK1 Kinase Inhibitors Using Structure-Based Pharmacophore Modelling and Molecular Docking

N. Al-Shar’i, 2020 .

Synthesis, biological evaluation, and computational investigation of ethyl 2,4,6-trisubstituted-1,4-dihydropyrimidine-5-carboxylates as potential larvicidal agents against Anopheles arabiensis.

N. Al-Shar’i, R. M. Gleiser, C. Tratrat, 2023, Journal of biomolecular structure & dynamics.

Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme

N. Al-Shar’i, M. Attimarad, Lina A. Dahabiyeh, 2021, Journal of enzyme inhibition and medicinal chemistry.

Identification of Possible Glyoxalase II Inhibitors as Anticancer Agents by a Customized 3D Structure-Based Pharmacophore Model

Mohammad A. Hassan, N. Al-Shar’i, Qosay A. E. Al-Balas, 2015 .